Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Lonza Buys Cell Technology Firm

June 2, 2008 | A version of this story appeared in Volume 86, Issue 22

Lonza has acquired Amaxa, a leader in gene-transfer technology, for an undisclosed sum. The Cologne, Germany-based firm manufactures systems that enable transfer of nucleic acids such as DNA and RNA into cells. Lonza says Amaxa will triple the size of its cell-related R&D operations based in Walkersville, Md. Amaxa's transfer technology is seen as complementary to Lonza's current activity, which is centered on primary cell production.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.